PHASE II RANDOMIZED CLINICAL TRIAL COMPARING ROPEGINTERFERON VERSUS.... EHA Library. Barbui T. Jun 14 2020; 303391
Haematologica 2000;85:supplement to no. 9 - Supplements ...
Haematologica
The haematocrit and platelet target in polycythemia vera - Di Nisio - 2007 - British Journal of Haematology - Wiley Online Library
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program | Blood Cancer Journal
Adopt a red blood cell: from Pavia to Vienna to Boston, the challenge of young investigators | Universitiamo
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT | Leukemia
Adopt a red blood cell: from Pavia to Vienna to Boston, the challenge of young investigators | Universitiamo
2 - Haematologica - Supplements
Elisa RUMI | Policlinico San Matteo Pavia Fondazione IRCCS, Pavia | San Matteo | s.c. Ematologia
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera | NEJM
Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group - Mora - 2020 - American Journal of Hematology - Wiley Online Library
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis | Bone Marrow Transplantation
Adopt a red blood cell: from Pavia to Vienna to Boston, the challenge of young investigators | Universitiamo
Maria Concetta Petti - European Medicines Agency
Facing erythrocytosis: Results of an international physician survey - Rumi - 2019 - American Journal of Hematology - Wiley Online Library
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera | NEJM
Cardiovascular Events and Intensity of Treatment in Polycythemia Vera | NEJM
Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group - Mora - 2020 - American Journal of Hematology - Wiley Online Library
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera | NEJM
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial - The Lancet Haematology
PDF) Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia
An NMR Study of the Bortezomib Degradation under Clinical Use Conditions – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
23rd Congress of EHA Final Program by Loyals - Issuu
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms | Blood Cancer Journal
Adopt a red blood cell: from Pavia to Vienna to Boston, the challenge of young investigators | Universitiamo
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera | NEJM
